UNIVERSAL HEALTH SERVICES INC 8-K
Research Summary
AI-generated summary
Universal Health Services Approves 2026 Executive Bonuses and Equity Awards
What Happened
Universal Health Services, Inc. (UHS) filed an 8‑K on March 30, 2026 reporting that its Compensation Committee on March 26, 2026 approved 2026 annual incentive bonus formulae and granted time‑based and performance‑based restricted stock units to senior executives. The Committee also approved a discretionary cash bonus of $1.07 million to Executive Chairman Alan B. Miller for the year ended December 31, 2025. Target annual incentive levels were set as a percentage of 2026 base salary (Marc D. Miller, CEO: 150%; Steve G. Filton, CFO: 100%; Edward H. Sim, EVP—Acute Care: 100%; Matthew J. Peterson, EVP—Behavioral Health: 100%).
Key Details
- Committee approval date: March 26, 2026; 8‑K filed March 30, 2026 and signed by Steve Filton (EVP & CFO).
- Annual incentive structure: payout range 0%–200% of target; corporate metrics for payouts include adjusted net income per diluted share and return on capital. For Messrs. Sim and Peterson, 25% of bonus tied to corporate metrics and 75% tied to divisional income (pre‑tax income net of cost of capital). For Messrs. Marc Miller and Filton, 100% tied to corporate metrics.
- Discretionary cash bonus: $1.07 million paid to Alan B. Miller for 2025.
- Equity awards (granted March 26, 2026, computed at $185.09 close): RSUs and PBRSUs awarded as follows (RSUs vest in four annual installments): Marc D. Miller — 29,715 RSUs and 29,715 PBRSUs; Alan B. Miller — 14,153 / 14,153; Steve G. Filton — 6,850 / 6,850; Edward H. Sim — 6,404 / 6,404; Matthew J. Peterson — 5,627 / 5,627.
- PBRSU metric changes: payout now based on the three‑year average of Adjusted EBITDA net of noncontrolling interest (2026–2028 average); minimum threshold 90% pays 50% of target, maximum threshold (110%+) pays 200% of target (up from prior 150% max); below 90% yields no payout.
Why It Matters
These actions show UHS’s executive pay remains closely tied to company and divisional financial performance, with potential upside or downside (0%–200%) based on results. The discretionary $1.07M bonus to the Executive Chairman is a notable one‑time cash payment disclosed for 2025. Changes to PBRSU measurement (three‑year averaging and higher maximum payout) increase the potential long‑term equity payout for executives and align UHS practices with peers; investors should note these changes when evaluating future diluted share impacts and executive incentives linked to Adjusted EBITDA and return metrics.